BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 30607549)

  • 1. CD73 expression in normal and pathological human hepatobiliopancreatic tissues.
    Sciarra A; Monteiro I; Ménétrier-Caux C; Caux C; Gilbert B; Halkic N; La Rosa S; Romero P; Sempoux C; de Leval L
    Cancer Immunol Immunother; 2019 Mar; 68(3):467-478. PubMed ID: 30607549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPARC expression in desmoplastic and non desmoplastic pancreatic carcinoma and cholangiocarcinoma.
    Khetan K; Baloda V; Sahoo RK; Vishnubhathla S; Yadav R; Saraya A; Sharma A; Gupta SD; Das P
    Pathol Res Pract; 2019 Dec; 215(12):152685. PubMed ID: 31727501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of CD73 expression and its relationship to PD-L1 in patients with radically treated pancreatic cancer.
    Tahkola K; Ahtiainen M; Kellokumpu I; Mecklin JP; Laukkarinen J; Laakkonen J; Kenessey I; Jalkanen S; Salmi M; Böhm J
    Virchows Arch; 2021 Feb; 478(2):209-217. PubMed ID: 32676968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules.
    Gandou C; Harada K; Sato Y; Igarashi S; Sasaki M; Ikeda H; Nakanuma Y
    Hum Pathol; 2013 May; 44(5):811-21. PubMed ID: 23134772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis.
    Ma XL; Shen MN; Hu B; Wang BL; Yang WJ; Lv LH; Wang H; Zhou Y; Jin AL; Sun YF; Zhang CY; Qiu SJ; Pan BS; Zhou J; Fan J; Yang XR; Guo W
    J Hematol Oncol; 2019 Apr; 12(1):37. PubMed ID: 30971294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecto-5'-nucleotidase (CD73) is a potential target of hepatocellular carcinoma.
    Shali S; Yu J; Zhang X; Wang X; Jin Y; Su M; Liao X; Yu J; Zhi X; Zhou P
    J Cell Physiol; 2019 Jul; 234(7):10248-10259. PubMed ID: 30417547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium.
    Ethun CG; Lopez-Aguiar AG; Pawlik TM; Poultsides G; Idrees K; Fields RC; Weber SM; Cho C; Martin RC; Scoggins CR; Shen P; Schmidt C; Hatzaras I; Bentrem D; Ahmad S; Abbott D; Kim HJ; Merchant N; Staley CA; Kooby DA; Maithel SK
    J Am Coll Surg; 2017 Apr; 224(4):406-413. PubMed ID: 28017812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD73 expression in normal, hyperplastic, and neoplastic thyroid: a systematic evaluation revealing CD73 overexpression as a feature of papillary carcinomas.
    Monteiro I; Missiaglia E; Sciarra A; Santos JV; Bouilly J; Romero P; Sempoux C; de Leval L
    Virchows Arch; 2021 Jul; 479(1):209-214. PubMed ID: 34019179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1.
    Radwan NA; Ahmed NS
    Diagn Pathol; 2012 Oct; 7():149. PubMed ID: 23111165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cellular origins of cancer with particular reference to the gastrointestinal tract.
    Alison MR
    Int J Exp Pathol; 2020 Oct; 101(5):132-151. PubMed ID: 32794627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Role of CD73/A2AR Expression and Tumor Immune Response in Periampullary Carcinoma Subtypes.
    Sweed D; Taha M; Abd Elhamed S; El Dein Mohamed AS
    Asian Pac J Cancer Prev; 2022 Apr; 23(4):1239-1246. PubMed ID: 35485681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hilar cholangiocarcinoma is pathologically similar to pancreatic duct adenocarcinoma: suggestions of similar background and development.
    Nakanuma Y; Sato Y
    J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):441-7. PubMed ID: 24446421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progenitor gene DLK1 might be an independent prognostic factor of liver cancer.
    Jin ZH; Yang RJ; Dong B; Xing BC
    Expert Opin Biol Ther; 2008 Apr; 8(4):371-7. PubMed ID: 18352842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
    Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
    Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD73 induces gemcitabine resistance in pancreatic ductal adenocarcinoma: A promising target with non-canonical mechanisms.
    Yu X; Liu W; Wang Z; Wang H; Liu J; Huang C; Zhao T; Wang X; Gao S; Ma Y; Wu L; Li X; Yang S; Hao J
    Cancer Lett; 2021 Oct; 519():289-303. PubMed ID: 34302921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXF1 as an Immunohistochemical Marker of Hilar Cholangiocarcinoma or Metastatic Pancreatic Ductal Adenocarcinoma. Single Institution Experience.
    Hrudka J; Prouzová Z; Mydlíková K; Jedličková K; Holešta M; Whitley A; Havlůj L
    Pathol Oncol Res; 2021; 27():1609756. PubMed ID: 34257615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BSEP and MDR3: Useful Immunohistochemical Markers to Discriminate Hepatocellular Carcinomas From Intrahepatic Cholangiocarcinomas and Hepatoid Carcinomas.
    Fujikura K; Yamasaki T; Otani K; Kanzawa M; Fukumoto T; Ku Y; Hirose T; Itoh T; Zen Y
    Am J Surg Pathol; 2016 May; 40(5):689-96. PubMed ID: 26735860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features.
    Papotti M; Sambataro D; Marchesa P; Negro F
    Liver; 1997 Feb; 17(1):47-52. PubMed ID: 9062880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver.
    Charlotte F; L'Herminé A; Martin N; Geleyn Y; Nollet M; Gaulard P; Zafrani ES
    Am J Pathol; 1994 Mar; 144(3):460-5. PubMed ID: 8129031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer.
    Faraoni EY; Singh K; Chandra V; Le Roux O; Dai Y; Sahin I; O'Brien BJ; Strickland LN; Li L; Vucic E; Warner AN; Pruski M; Clark T; Van Buren G; Thosani NC; Bynon JS; Wray CJ; Bar-Sagi D; Poulsen KL; Vornik LA; Savage MI; Sei S; Mohammed A; Zhao Z; Brown PH; Mills T; Eltzschig HK; McAllister F; Bailey-Lundberg JM
    Cancer Res; 2023 Apr; 83(7):1111-1127. PubMed ID: 36720042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.